Search all bills

TOTAL RESULTS: 4139

• Therapeutic Goods Amendment Bill (No. 3) 2006

  Track (What's this?)

  Date

  11 May 2006 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Amends the

  Therapeutic Goods Act 1989

  to allow manufacturers of medicines, blood and tissues to apply for a manufacturing licence electronically using the Therapeutic Goods Administration’s e-business system. 

  Bill | Explanatory Memorandum

• National Health and Medical Research Council Amendment Bill 2006

  Track (What's this?)

  Date

  29 Mar 2006 

  Chamber

  Senate 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Following government endorsement of the recommendations of the Review of the Corporate Governance of Statutory Authorities and Office Holders (the Uhrig Review) and 2 other reviews, the bill amends the

  National Health and Medical Research Council Act 1992

  to: introduce new governance arrangements including establishing, from 1 July 2006, the National Health and Medical Research Council (NHMRC) as a statutory agency subject to the

  Public Service Act 1999

  and the

  Financial Management and Accountability Act 1997

  ; and clarify the accountability and reporting functions of the NHMRC. Also makes consequential amendments to 7 other Acts. 

  Bill | Explanatory Memorandum

• Health and Other Services (Compensation) Amendment Bill 2006

  Track (What's this?)

  Date

  02 Mar 2006 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Amends the

  Health and Other Services (Compensation) Act 1995

  to: repeal the sunset clause (due to take effect on 1 July 2006) to enable the continuation of the Advanced Payment Option for compensation claimants to access the major proportion of compensation money at the time of their judgement or settlement; remove the definition of “fatal injury” to ensure that Commonwealth benefits paid in situations involving a fatal injury or disease must also be repaid after judgement or settlement; provide a formal pathway for review of certain decisions; replace certain superseded wording; and clarify the value of a “small amount”. 

  Bill | Explanatory Memorandum

• Cancer Australia Bill 2006

  Track (What's this?)

  Date

  16 Feb 2006 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Establishes Cancer Australia as a new statutory agency in relation to coordination of cancer control, cancer treatment and management, cancer research and implementation of cancer policies and priorities. Also provides for the terms of appointment and roles of the Chief Executive Officer, support staff and the Cancer Australia Advisory Council. 

  Bill | Explanatory Memorandum

• Health Legislation Amendment (Pharmacy Location Arrangements) Bill 2006

  Track (What's this?)

  Date

  16 Feb 2006 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Amends the

  National Health Act 1953

  to: extend the operation of pharmacy location rules and their administration by the Australian Community Pharmacy Authority (ACPA) to 30 June 2010; increase the membership of the ACPA to include a consumer representative; provide for a Ministerial discretionary power in relation to approval of a pharmacist; clarify the Secretary’s ability to approve more than one pharmacist to supply pharmaceutical benefits in respect of particular premises and the Minister’s power to determine conditions relating to premises applying to approval to supply pharmaceutical benefits; simplify the approval process for pharmacists wishing to expand or contract their premises; and make minor technical amendments. 

  Bill | Explanatory Memorandum

• Health Legislation Amendment Bill 2005

  Track (What's this?)

  Date

  14 Sep 2005 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Amends the

  National Health Act 1953

  to: extend, until 30 June 2006, the existing arrangements for approving pharmacists to supply medicines subsidised under the Pharmaceutical Benefits Scheme; clarify that dependants of contributors to a health benefits fund with appropriate cover, as well as the contributors, are covered by the fund;

  Health Insurance Act 1973

  to: clarify the scope of the power to make Medicare Tables; and enable the Minister to make legislative instruments determining that Medicare benefits are not payable for professional services in specified circumstances; and

  Medical Indemnity Act 2002

  to replace references to the Health Insurance Commission with references to the Chief Executive Officer of Medicare Australia. 

  Bill | Explanatory Memorandum

• National Health Amendment (Budget Measures—Pharmaceutical Benefits Safety Net) Bill 2005

  Track (What's this?)

  Date

  14 Sep 2005 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Amends the

  National Health Act 1953

  to: exclude early supply of certain pharmaceutical benefits scheme (PBS) medicines from safety net entitlements and apply standard patient co-payments to such supplies; and increase the PBS Safety Net threshold. 

  Bill | Explanatory Memorandum

• National Health Amendment (Immunisation Program) Bill 2005

  Track (What's this?)

  Date

  14 Sep 2005 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Amends the

  National Health Act 1953

  in relation to vaccine funding advisory arrangements under the National Immunisation Program (NIP), including extending the functions of the Pharmaceutical Benefits Advisory Committee to providing the Minister with advice about vaccines to be funded under the NIP. 

  Bill | Explanatory Memorandum

• Therapeutic Goods Amendment Bill (No. 2) 2006

  Track (What's this?)

  Date

  14 Sep 2005 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Amends the

  Therapeutic Goods Act 1989

  to narrow the circumstances in which patent certification is required by applicants seeking to list or register a therapeutic good on the Australian Register of Therapeutic Goods. 

  Bill | Explanatory Memorandum

• Therapeutic Goods Amendment Bill (No. 1) 2006

  Track (What's this?)

  Date

  17 Aug 2005 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Amends the

  Therapeutic Goods Act 1989

  to provide the Therapeutic Goods Administration with additional sanctions and enforcement options for dealing with suppliers and manufacturers who fail to comply with regulatory requirements including product and manufacturing standards, including: introduction of a tiered offence regime and civil penalties for breaches; providing for infringement notices, enforceable undertakings and strict liability offences; and extending territorial jurisdiction in certain circumstances. Also makes a consequential amendment to the

  Therapeutic Goods Amendment (Medical Devices) Act 2002

  . 

  Bill | Explanatory Memorandum